52 results about "Flemingia macrophylla" patented technology

The invention relates to a method for extracting genistin from largeleaf flemingia. The method comprises the following steps: (1) chopping the raw material largeleaf flemingia and performing reflux extraction by use of ethanol water having the concentration of 50-70% to obtain an extract; (2) concentrating the extract obtained in the step (1) and putting on a chromatographic column, wherein the fixed phase in the chromatographic column is macroporous adsorption resin; eluting with an ethanol-water solution in the volume ratio of (15-25): (85-75) as a moving phase and collecting the eluate; and (3) concentrating the eluate obtained in the step (2) into a thick extract, adding ethanol containing 2-3% of glacial acetic acid for thorough dissolving, standing, filtering out insoluble substances, recrystallizing the filtrate, washing crystals by use of ethanol, and drying in vacuum to obtain the genistin. The method has the advantages of rich and easily available raw materials, simple and feasible process, low pollution and short period; and the obtained product is high in purity and prone to large-scale preparation.

The invention provides a method for trapping and killing tea lesser leafhoppers with a plant repellent and an attractant in a push-pull manner. The 41-51mg / mL attractant is prepared from the followingvolatile matters from branches and leaves of flemingia macrophylla at a proportion: cis-3-hexen-1-ol, cis-3-hexen-acetic ester, ocimene, methyl salicylate, cis-3-hexen-butyric ester, dodecane, hexadecane and nonanal. The 15-25mg / mL of two-component repellent is prepared from the following ingredients at a proportion: thymol and 2-isopropyl-4-methyl anisole. The tea lesser leafhoppers prevail frommid-May to mid-July and from September to November every year, a lure loaded with the repellent is bound in tea bushes during prevailing, and the leafhoppers are repelled out by the repellent; meanwhile, a bud green sticky board with an attractant lure is fixed above the tea bushes, and the leafhoppers are attracted to the sticky board by the attractant; 15-20 sets of 'push-pull' combinations areplaced per mu, so that a large amount of leafhoppers are trapped and killed, and green prevention and control can be achieved.

The invention discloses a traditional Chinese medicine composition for treating sciatica. The traditional Chinese medicine composition is composed of the following raw materials in parts by weight: 2-4 parts of salviae miltiorrhizae, 5-7 parts of schisandra chinensis, 3-4 parts of radix rehmanniae preparata, 2-4 parts of euphorbia kansui, 4-6 parts of kadsura pepper stem, 1-3 parts of scorpio, 3-5 parts of cortex Illicii, 8-10 parts of cistanche, 6-8 parts of erycibe obtusifolia benth, 1-3 parts of elaeagnus oldhamii maxim, 2-3 parts of myoporum bontioides, 4-6 parts of rhizoma drynariae, 2-4 parts of cortex acanthopanacis, 5-7 parts of lycopodium clavatum, 5-7 parts of Sichuan lovage rhizome, 1-2 parts of flemingia macrophylla, 2-3 parts of saururus chinensis, 3-5 parts of radix angelicae sinensis, 1-3 parts of iiex asprella and 2-4 parts of justicia gendarussa; the traditional Chinese medicine composition disclosed by the invention has the functions of relieving rigidity of muscles and activating collaterals, promoting blood circulation to remove blood stasis, inducing menstruation to relieve menalgia, dispelling wind and eliminating dampness, and the like, has a better effect on expelling wind-damp and freeing the channels and network vessels, can be used for effectively treating sciatica, and is convenient to use, significant in treatment effect and free of any toxic or side effect.

The invention discloses traditional Chinese medicine powder for treating postoperative upper limb edema of a breast cancer. Traditional Chinese medicine believes the disease is caused by injuried blood vessels and nerves to result in unsmooth qi and blood circulation, subcutaneous water flow, blood stasis and internal retention, a patient has insufficient vital qi originally, and vitality is injured by postoperative radiotherapy and chemotherapy, and the patient is incapable of promoting blood circulation to result in the blood stasis, phlegm dampness and retention, thereby causing the disease. Accordingly, the traditional Chinese medicine powder adopts begonia fimbristipula, clinacanthus nutans, a discadenoid cherry root, gynura divaricata, a dichrocephala root, clerodendrum indicum, splendid achnatherum, desmodium heterocarpon, flemingia macrophylla, a radix fici simplicissimae root, railway beggarticks herb, and primrose willow which are ground, bagged and heated for external application. Clinical trials show the powder has a total effective rate up to 93.33%, and a significant curative effect.

The invention discloses an artificial propagation method of big leaves moghania, comprising the steps of harvesting seeds, seedbed establishment, seed treatment, planting and pregermination, seedbed management, bagging, bed out and nursery management, etc. The invention utilizes the big leaves moghania seeds to culture nursery stock, and firstly realizes the artificial propagation of the big leaves moghania, thus providing sufficient materials for production of enterprises and realizing scientific utilization of plant resources; while helping farmers shake off poverty and set out on a road toprosperity, environment is protected, water loss and soil erosion is prevented, and the invention is provided with a good market application prospect.

The invention provides a traditional Chinese medicine for curing liver-kidney asthenia femoral head necrosis and a preparation method thereof. The traditional Chinese medicine comprises the following crude drugs: membranaceous beautyleaf roots, giantleaf ardisia rhizome, Aristolochia impressinervis C. F. Liang, black sesame seeds, adenia chevali, mussel, roots of wallich swallowwort, flatstem astragalus seeds, Lindera metcalfiana Allen var.dictyophylla (Allen) H. P. Tsui, asiatic bilberry, winter creeper, herb of whixh plant, sambucus adnata, pyrola, the old green, Flemingia macrophylla (Willd.) Prain, byttneria aspera colebr and stems of manyflower fissistigma. The traditional Chinese medicine has an exact curative effect on liver-kidney asthenia femoral head necrosis, and has small toxic and side effects.

The invention relates to traditional Chinese medicine tea, in particular to bagged oral medicinal tea for treating lumbar muscle strain. The medicinal tea is prepared from the following raw materials: 40-45g of rhizoma atractylodis, 40-45g of cortex phellodendri, 35-40g of peach leaf, 35-40g of delavay stephania root, 45-50g of moghania macrophylla root and 50-55g of tea leaves. The bagged oral medicinal tea provided by the invention has the characteristics of novel formula of raw materials, quick absorption and good effect, and is easy to prepare and convenient to use.

The invention discloses a traditional Chinese medicine preparation capable of treating third lumbar transverse process syndrome. According to the theory of the traditional Chinese medicine, the symptom cause of third lumbar transverse process syndrome is external evil, or stumble, falling, sudden sprain and contusion, and the root cause is kidney deficiency. In the traditional Chinese medicine preparation provided by the invention, the traditional Chinese medicinal materials with the efficacies of expelling wind and removing cold, eliminating dampness and heat, invigorating blood circulation and easing pain, and nourishing liver and kidney, such as grossedentate clematis root, ardisia villosa, heterophyllous wing seedtree root, Ficus erecta Thumb.var.beecheyana (Hook.et Arn.) King [F.beecheyana Hook.et Arn.], flemingia macrophylla (willd.) prain, polygonum cuspidatum, goldhair hedyotis herb, morinda officinalis, eclipta, glossy privet fruits, Chinese holly, and Schisandra lancifolia(Rehd.et.Wils)A.C.Smith[S.sphenantheraRehd,etWils.var.lanci-folia Rehd.et.Wils are adopted, and decocted by water to prepare the decoction. Through the clinical test, the total effective rate achieves 97.5%, which is obviously superior to that the control group, and thus the traditional Chinese medicine preparation is worthy of popularization and application.

The invention relates to the technical field of medicines, discloses a preparation method of a phenylpropanoid compound, and particularly relates to a phenylpropanoid compound which is obtained by being separated from dried roots of moghania macrophylla (Willd.) O Ktze.. The phenylpropanoid compound is prepared through the steps of solvent extraction, column chromatographic separation and liquid phase preparation, separation and purification. The phenylpropanoid compound obtained through the method is reported for the first time and is high in purity. It is proved through experiments that the obtained novel phenylpropanoid compound can inhibit expression effects of cell inflammatory factors of TNF-alpha, IL-1 beta and IL-6, has an inhibiting effect on hydroxyl free radicals (-OH), has anti-inflammatory and antioxidant activities, is beneficial for treatment of various inflammatory diseases such as cervicitis, endometritis, pelvic inflammation, mastitis, faucitis and / or arthritis and can be developed into a novel drug. The compound is the phenylpropanoid compound with the structural formula as shown in a formula (I) and pharmaceutically acceptable salts thereof. Please see the formula (I) in the description.